Table I. RA cohort demographics and clinical characteristics.

N	14
Age (y; mean ± SD)	51.2 ± 13.3
Gender	86% female
CRP (μg/ml)	14.27 ± 19.7
CCP titer (IgG)	76.9%
DMARD
Methotrexate	78.6%
Antimalarial	71.4%
Anti-TNF	42.9%

Number of patients on other drugs: mycophenolate mofetil (1), corticosteroids (6), azathioprine (1), and leflunomide (1).

CRP, C-reactive protein; CCP, cyclic citrullinated peptide; DMARD, disease-modifying antirheumatic drug.